Since atherosclerosis is generally studied in hyperlipidemic mice rather than in rats, we set out to validate the effect of NPY on hepatic VLDL-TG production in mice, with the ultimate goal to investigate whether NPY, by increasing VLDL-TG production, contributes to the development of atherosclerosis. This evidence concerns the gene NPY and atherosclerosis.